The Medigard Blood Collection Device

The Medigard Blood Collection Device (BCD) features inventive vacuum technology to capture the needle after blood has been collected.

This prevents needlestick injury by eliminating human contact with used needles. It avoids potential aerosoling, a dangerous spray of fluid getting into the air when the needle is retracted.

Medigard's unique BCD is easy to use and technically superior to other safety blood collection devices.

Extensive product testing has found healthcare workers in the US and Australia unequivocally prefer Medigard's BCD to other products on the market.

Medigard's BCD vacuum design and minimal parts means a lower cost of production and a competitive price. The Medigard BCD has a shelf life of at least five years.

Key Benefits

Adaptable

Medigard products use the international standard Luer connection enabling the interchange of needles.

Safe

Medigard products protect healthcare workers from needlestick injuries. More than 20 different blood borne disease, including HIV-AIDS, Hepatitis B and C can be transmitted by needlestick injury.

More than 1 million cases of needlestick injury to healthcare workers are reported worldwide each year.

Unique

Medigard developed the vacuum retraction technology in-house.

Effective

Medigard products avoid dangerous aerosoling (blood spatter) during needle retraction.

Affordable

Medigard products contain fewer parts, are easier to manufacture and price competitive.